June 25, 2019 | City of Hope
City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.
ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL
June 28, 2019 | City of Hope
At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.
City of Hope awarded $7.5M to develop treatment for rare cancer
April 3, 2019 | Zen Vuong
City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.
Finding better treatments for devastating rare diseases
February 27, 2019 | Abe Rosenberg
City of Hope has long been renowned for its expertise in treating cancer and diabetes. But specialists here also are tackling lesser-known but equally devastating diseases that may or may not have an oncologic component.
City of Hope Physicians Announce New CAR T Breakthroughs at Annual ASH Meeting
December 14, 2017 | Letisia Marquez
New blood cancer breakthroughs – including several involving CAR T cell therapy – were announced by City of Hope physicians at the American Society of Hematology (ASH) annual meeting in Atlanta.